Back to search
Antibody Mediated Rejection After Kidney Transplantation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Antibody Mediated Rejection After Kidney Transplantation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Antibody Mediated Rejection After Kidney Transplantation trials you may qualify forThe primary objective of this study is to evaluate the efficacy of ALXN2030 compared with placebo on biopsy proven histologic resolution in participants with ac…
Humoral rejection of kidney transplants is responsible for a large number of kidney graft losses in a context of increasing shortage. Although it has been esta…
Antibody mediated rejection (ABMR) is a major cause of graft loss after kidney transplantation (KT) and is mainly associated with preformed anti-HLA donor speci…
The aim of this trial is to collect data and provide a better understanding of the long-term outcome of imlifidase treatment on active or chronic active antibod…